Last updated on February 2018

Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis


Brief description of study

The purpose of this study is to evaluate the effect of tobramycin inhalation solution (TIS) once daily compared tot placebo in patients with non-CF bronchiectasis. The primary endpoint is a reduction of exacerbations of the disease during the treatment period. Next to this parameter the investigators expect to show a significant beneficial effect on lung function parameters, QoL, bacterial load of pathogens in sputum and tobramycin resistance.

Clinical Study Identifier: NCT02657473

Find a site near you

Start Over

North West Clinics

Alkmaar, Netherlands
  Connect »